Diana Elkis
Executive Director, Portfolio Strategy Implementation & Reporting, Global Drug Development at BMS
- Role
- Exec Director, Portfolio Insights & Reporting, Global Drug Development at Bristol Myers Squibb
- Location
- Princeton, NJ, US
- LinkedIn followers
- 500 followers
About Diana Elkis
As seasoned bio-pharmaceuticals and life sciences professional, Diana is responsible for leading the operations and strategic planning efforts in AstraZeneca.
Experience
Exec Director, Portfolio Insights & Reporting, Global Drug Development
Oct 2023 — Present · Princeton, NJ, US
Leads Global Drug Development Portfolio Strategy Implementation & Reporting (PSI & R) team to enable effective portfolio execution & risk management across BMS\' five therapeutics areas, part of the Portfolio & Strategic Operations Office of the Global Drug Development Head & CMO. The PSI & R team connects portfolio decisions end-to-end, leads external & internal pipeline reporting, drives enhanced portfolio insights working with the senior drug development leadership and across the enterprise.
Education
Krasnoyarsk State Medical University (KrasSMU)
Completed 3 Years
1987 — 1990
Tel Aviv University
Master of Science (MSc), Cell Biology and Immunology
1993 — 1995
Loyola University Maryland Sellinger School of Business and Management
Master of Business Administration (MBA), Finance
2000 — 2003
Tel Aviv University
Bachelor of Science (B.Sc.), Microbiology
1991 — 1993
Skills
- Business Transformation
- Management Consulting
- Cross-Functional Team Leadership
- Business Strategy
- Business Process Improvement
- Strategic Planning
- Mergers & Acquisitions
- Program Management
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.